Shares

22 transactions
Quarter Operation Price Per share shares change shares Held SEC Form
Q2 2023

Aug 14, 2023

BUY
$5.9 - $6.95 $144,437 - $170,142
24,481 Added 57.62%
66,968 $441,000
Q1 2023

May 08, 2023

SELL
$6.18 - $7.99 $80 - $103
-13 Reduced 0.03%
42,487 $288,000
Q4 2022

Feb 14, 2023

SELL
$6.87 - $10.96 $4,809 - $7,672
-700 Reduced 1.62%
42,500 $314,000
Q3 2022

Nov 10, 2022

BUY
$9.44 - $11.76 $130,272 - $162,288
13,800 Added 46.94%
43,200 $427,000
Q1 2022

May 04, 2022

SELL
$10.84 - $16.55 $43,761 - $66,812
-4,037 Reduced 12.07%
29,400 $332,000
Q4 2021

Feb 14, 2022

SELL
$15.69 - $21.14 $9,414 - $12,684
-600 Reduced 1.76%
33,437 $525,000
Q3 2021

Nov 08, 2021

SELL
$15.35 - $21.27 $1,535 - $2,127
-100 Reduced 0.29%
34,037 $584,000
Q1 2021

May 13, 2021

SELL
$13.42 - $20.28 $369,788 - $558,815
-27,555 Reduced 44.67%
34,137 $513,000
Q4 2020

Feb 09, 2021

SELL
$9.77 - $13.81 $398,352 - $563,075
-40,773 Reduced 39.79%
61,692 $809,000
Q3 2020

Nov 09, 2020

SELL
$9.32 - $12.02 $393,238 - $507,159
-42,193 Reduced 29.17%
102,465 $990,000
Q2 2020

Aug 12, 2020

SELL
$9.66 - $12.02 $8,182 - $10,180
-847 Reduced 0.58%
144,658 $1.66 Million
Q1 2020

May 04, 2020

BUY
$7.5 - $16.8 $202,800 - $454,272
27,040 Added 22.83%
145,505 $1.51 Million
Q4 2019

Feb 12, 2020

SELL
$12.38 - $17.47 $346,206 - $488,548
-27,965 Reduced 19.1%
118,465 $1.94 Million
Q3 2019

Nov 12, 2019

BUY
$12.27 - $15.79 $402,456 - $517,912
32,800 Added 28.87%
146,430 $1.95 Million
Q2 2019

Aug 16, 2019

SELL
$13.37 - $18.85 $13,597 - $19,170
-1,017 Reduced 0.89%
113,630 $1.6 Million
Q1 2019

May 13, 2019

BUY
$17.59 - $31.05 $1.33 Million - $2.34 Million
75,519 Added 193.01%
114,647 $2.11 Million
Q4 2018

Feb 05, 2019

SELL
$18.97 - $31.47 $29,403 - $48,778
-1,550 Reduced 3.81%
39,128 $1.02 Million
Q2 2018

Aug 10, 2018

SELL
$13.95 - $19.15 $82,305 - $112,984
-5,900 Reduced 12.67%
40,678 $775,000
Q1 2018

May 08, 2018

BUY
$14.05 - $20.2 $8,134 - $11,695
579 Added 1.26%
46,578 $784,000
Q4 2017

Feb 13, 2018

BUY
$12.85 - $18.1 $514,000 - $724,000
40,000 Added 666.78%
45,999 $698,000
Q3 2017

Nov 07, 2017

BUY
$15.4 - $18.85 $3,572 - $4,373
232 Added 4.02%
5,999 $107,000
Q2 2017

Nov 20, 2017

BUY
N/A
5,767
5,767 $94,000

Others Institutions Holding VNDA

About Vanda Pharmaceuticals Inc.


  • Ticker VNDA
  • Exchange NASDAQ
  • Sector Healthcare
  • Industry Biotechnology
  • Shares Outstandng 56,561,500
  • Market Cap $271M
  • Description
  • Vanda Pharmaceuticals Inc., a biopharmaceutical company, focuses on the development and commercialization of therapies to address high unmet medical needs. The company's marketed products include HETLIOZ for the treatment of non-24-hour sleep-wake disorders; and Fanapt oral tablets for the treatment of schizophrenia. Its products under developme...
More about VNDA
Track This Portfolio

Track Clari Vest Asset Management LLC Portfolio

Follow Clari Vest Asset Management LLC and customize your updates to receive the information that matters most to you.

Portfolio Update

Get notified when there are updates to the investment portfolio of Clari Vest Asset Management LLC, based on Form 13F filings with the SEC.

News

Stay updated on Clari Vest Asset Management LLC with notifications on news.